Metablok

N/A

Report date: 2022/11/20 14:49:22
NME

Base Information

Drug NameMetablok
Drug Alias NameLSALT peptideLSALT肽
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionRenal dipeptidase inhibitors
TargetsRenal dipeptidase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Heart DiseasesAcute Kidney Injury +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTurkey +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Calgary
China Registration ClassN/A

Develop Information

Active CompaniesArch Biopartners Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Heart DiseasesAcute Kidney Injury +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A